title: V. Molecular classification and risk stratification of myeloma.
authors.affiliation: Mayo Clinic, Scottsdale, AZ 85259, USA. Bergsagel.leif@mayo.edu
authors.forename: P Leif
authors.initials: PL
authors.lastname: Bergsagel
authors.forename: Marta
authors.initials: M
authors.lastname: Chesi
mesh_terms: D056741:Cyclin D / Q000235:genetics; D018450:Disease Progression; D015972:Gene Expression Regulation, Neoplastic; D020022:Genetic Predisposition to Disease; D011495:Histone-Lysine N-Methyltransferase / Q000235:genetics; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000235:genetics; D009101:Multiple Myeloma / Q000145:classification / Q000175:diagnosis* / Q000235:genetics*; D051257:Proto-Oncogene Proteins c-maf / Q000235:genetics; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000235:genetics; D012097:Repressor Proteins / Q000235:genetics; D014178:Translocation, Genetic; D014314:Trisomy / Q000235:genetics
chemical_list: D056741:Cyclin D; D007143:Immunoglobulin Heavy Chains; D051257:Proto-Oncogene Proteins c-maf; D012097:Repressor Proteins; D011495:Histone-Lysine N-Methyltransferase; C419586:NSD2 protein, human; D051498:Receptor, Fibroblast Growth Factor, Type 3